< img src = "/uploads/1786608747626-tnbait.jpg "alt =" New Journey · Peptide Wonderful Invitation Cover "style =" max-width: 100%; height: auto; border-radius: 6px; box-shadow: 0 2px 12px rgba (0,0,0,0.08); "/>
On September 2, 2026, the opening ceremony of the micropeptide group Zhaoqing factory under the theme of "New Journey · Peptide Wonderful" will be held in Zhaoqing, Guangdong and Guangzhou.In the morning, the opening ceremony of the Zhaoqing Smart Factory will be held in the factory building A8, No. 2 Wende 5th Street, Zhaoqing High-tech Zone; in the afternoon, the new product launch meeting and the theme summit of "Medical Research Co-creation · Cosmetics Co-operation" will be held in the Qinghe Hall on the 1st floor of Building 1 of Guangzhou Baiyun International Conference Center; in the evening, the thanks dinner will be held at the same venue, and there will be a surprise draw on the spot.
This is not only the inauguration of a new plant, but also a key point for the Micropeptide Group (WESTAI Micropeptide Biology) from manufacturing to intelligent manufacturing strategy.With the foundation of "medical research and co-creation" and the wing of "cosmetics union", Micropeptide is committed to providing partners with more technical and effective skin care solutions.
From Manufacturing to Smart Manufacturing: Strategic Ascension of Micropeptides
Guangdong Micropeptide Biotechnology Co., Ltd. (Unified Social Credit Code: 91440605MA53EH1G99) was established in 2012 with a registered capital of 50 million yuan. It is a national high-tech enterprise integrating R&D, production and sales.Over the past ten years, Micropeptide has started from a single production base and gradually developed into an industrial group with four major production bases in Guangzhou Baiyun, Foshan Nanhai, Hunan Changshan Ningxiang, and Zhaoqing High-tech Zone, with a total area of more than 300,000 square meters. There are more than 1,000 cooperative brands, helping more than 100 products to complete the registration and listing.
The commissioning of the Zhaoqing Smart Factory is another leap in the development of micropeptides.It carries not only the expansion of production capacity, but also the overall upgrading of production models - from experience-driven to data-driven, from labor-intensive to automated collaboration, from single base to multi-base network scheduling.Micropeptides are interpreting the weight of the word "smart" with practical actions.
< img src = "/uploads/1786608747769-2p7rqn.jpg "alt =" Invitation Body "style =" max-width: 100%; height: auto; border-radius: 6px; box-shadow: 0 2px 12px rgba (0,0,0,0.08); "/>
< img src = "/uploads/1786608748648-mzdokb.jpg" alt = "Zhaoqing Factory Opening Owner Vision KV" style = "max-width: 100%; height: auto; border-radius: 6px; box-shadow: 0 2px 12px rgba (0,0,0,0.08); "/>
Co-creation of medical research: building a collaborative innovation system for industry-university-research
"Medical research co-creation" is not a slogan, but an innovative methodology of continuous investment in micropeptides.The core is to open up the complete link of "clinical needs — basic research — product development — industrialization", so that the R&D direction can truly respond to the real needs of the market and consumers.
Continuous accumulation of technical achievements
As a national high-tech enterprise, Micropeptide has cumulatively produced more than 70 technical achievements, covering peptide applications, formulation processes, quality control, efficacy evaluation and other aspects, and participated in the formulation of 3 cosmetics industry standards.These technical achievements are not the papers of the Bundled Gakkaku, but are directly translated into mass-producible, reproducible process parameters and product solutions.
Industry-university-research collaboration
Micropeptides actively establish cooperative relationships with scientific research institutions, universities and industry experts, and conduct joint research on efficacy skin care raw materials, dosage form innovation, and safety evaluation.Through industry-university-research collaboration, micropeptides introduce cutting-edge scientific research results into the industrialization channel, shortening the distance from the laboratory to the production line.On the afternoon of September 2, at the "Medical Research Co-creation" theme summit, some cooperation results will be publicly announced for the first time.
Efficacy Validation Closed Loop
In the era of efficacy skincare, "claiming to be justified" is a basic requirement.Micropeptides establish a complete validation process from formulation screening, stability testing to efficacy evaluation, ensuring that every product brought to market is supported by data.This is both responsible to the brand and to the end consumer.
Cosmetics Consortium: Strategic Layout of Dual Track Synergy
The Micropeptide Group has 3 cosmetic number factories and 1 Class II medical device production factory, forming an industrial pattern with dual tracks for cosmetics and medical devices.This "cosmetics union" layout is not common in the industry, and its synergistic advantages are reflected in multiple levels.
Complementary qualifications to meet diverse needs
Cosmetics and Class II medical devices have requirements in the regulatory system, production environment, and quality standards.Micropeptides have both production qualifications and capabilities. Brands can complete the layout of cosmetics and equipment products at the same partner, reduce multi-vendor management costs, and shorten product launch cycles.Its Class II medical device factories have passed ISO 13485 medical device quality management system certification, and the quality control standards are in line with international standards.
Technology sharing, quality mutual empowerment
Medical device production has extremely strict requirements for cleanliness, process control and traceability systems.Micropeptide introduces the fine management experience in device production into the cosmetic production line, which improves the overall quality control level of cosmetic production. At the same time, the accumulation of skin adjustment, dosage form innovation and consumer experience in the field of cosmetics also provides a reference for the optimization of the use experience of device products.The technical and managerial experience of the two tracks empowers each other, creating a synergy of "1 +1 > 2".
Market synergy to embrace efficacy skin care megatrends
The current efficacy skin care market continues to heat up, and brands increasingly need a "makeup + equipment" product matrix to meet the needs of different scenarios and different channels.The combined cosmetic layout of micropeptides coincides with this trend, providing brands with a complete product solution from daily chemistry line to professional line, from daily care to efficacy enhancement.All products are filed or registered in strict accordance with the corresponding laws and regulations, and compliance is a priority.
Zhaoqing Smart Factory: Analysis of Digital Intelligent Manufacturing Capabilities
The Zhaoqing Smart Factory is a concentrated embodiment of the micropeptide "smart manufacturing" concept.The new factory was designed with digitalization and automation as its core objectives.
Intelligent production system
The factory is equipped with automated emulsification, filling and packaging production lines, and the key processes realize equipment linkage and precise control of parameters, reducing batch fluctuations caused by human operation.Production data is collected and uploaded in real time, and management personnel can keep track of the operation status and production progress of each production line at any time.
Whole process quality traceability
The digital quality management system covers the entire process of raw material acceptance, semi-finished product inspection, and finished product release. The test data, operators, and release records of each batch can be traced.This system meets the traceability requirements of cosmetics GMP and medical device quality management at the same time, providing a unified digital quality control base for cosmetics dual-track products.
High standard production environment
The factory is built in accordance with the quality management specifications for cosmetics production and the relevant requirements for medical device production. The temperature and humidity, pressure difference, and cleanliness of the clean workshop are all monitored and automatically adjusted in real time to provide environmental protection for product quality.
Flexible capacity allocation
The production line design takes into account high-volume orders and multi-variety small-volume needs, and can quickly switch categories and specifications to meet the production capacity needs of the brand at different stages of development.With the coordinated scheduling of the four major bases, the delivery resilience and anti-risk ability have been significantly improved.
< img src = "/uploads/1786608748789-rlou06.jpg "alt =" Zhaoqing Smart Factory Appearance Rendering "style =" max-width: 100%; height: auto; border-radius: 6px; box-shadow: 0 2px 12px rgba (0,0,0,0.08); "/>
< img src = "/uploads/1786608747913-sdraxt.jpg" alt = "Invitation Schedule Express" style = "max-width: 100%; height: auto; border-radius: 6px; box-shadow: 0 2px 12px rgba (0,0,0,0.08); "/>
National layout of the four bases: continuous release of synergies
With the addition of the Zhaoqing factory, the micropeptide group has formed a pattern of four bases covering southern China and the central part of the radiation:
- Guangzhou Baiyun Base: Close to the core area of the beauty industry in South China, undertaking R&D proofing and core product production functions, convenient transportation, and convenient for brand field visits and communication.
- Foshan Nanhai Base: A large-scale production base with mature supply chain support and production experience to undertake large-scale orders.
- Hunan Changsha Ningxiang Base: Radiate the central market, shorten the logistics radius of inland customers, reduce transportation costs, and improve delivery timeliness.
- Zhaoqing High-tech Zone Base: Intelligent manufacturing upgrades the new engine, builds with high automation and high digital standards, and undertakes the transformation of future-oriented production capacity needs and technological innovation results.
The four major bases have uniformly implemented the Micropeptide Group quality manual and standard system, and have passed ISO 22716, US GMPC, ISO 13485 and other certifications to ensure the consistent quality of products produced at different bases.The total area exceeds 300,000 square meters of production capacity, providing solid hardware support for serving more than 1,000 cooperative brands.
Full link cooperation model: covering all stages of brand growth
The Zhaoqing Smart Factory was put into operation, further broadening the service boundary of Micropeptide Group.Regardless of the stage of development of the partner, you can find a matching way of cooperation in the service system of micropeptides:
- OEM processing OEM: The brand side provides mature formula and packaging material design, and the factory organizes production according to unified standards, which is suitable for brands that have accumulated formula and need to quickly expand production capacity.
- ODM full link service: from formulation research and development, packaging material design, filing and declaration to mass production delivery in one place, to help start-up brands shorten the new product launch cycle.
- Merchants: Provide brand planning, training system, terminal materials and other supporting support to help entrepreneurs quickly enter the beauty industry.
- Beauty salon line: Customized products for professional cinema line channels, differentiated from cosmetic lines in terms of efficacy positioning, skin experience, and packaging specifications.
- Limited brand spot: Stock up on mature formulas and finished products that have been filed, support fast pickup in small batches, reduce brand thresholds and inventory risks, especially suitable for testing new products or testing market responses.
The dual-course qualification of the cosmetics association also allows the brand to complete the coordinated layout of cosmetics and second-class medical devices at the same partner, reducing the cost of multi-head docking.
Invitation to the 2nd of September: Three Events, One Meeting
Micropeptide Group sincerely invites partners and industry colleagues to come and witness this important moment together.
- Morning · Opening ceremony: Zhaoqing Smart Factory on-site visit to witness the start-up and operation of the smart production line.Address: Plant A8, No. 2, Wende 5th Street, Zhaoqing High-tech Zone.
- Afternoon · New Product Launch Meeting & Medical Research Co-creation Theme Summit: The industry-leading results were unveiled, and the industry-university-research guests talked about the innovative path of skin care.Address: Qinghe Hall, 1st Floor, Building 1, Guangzhou Baiyun International Convention Center.
- Evening · Thanksgiving dinner: Thanks to the dinner party, we have been trusting and supporting micropeptide partners for a long time, and set up a surprise draw on the spot.Address: Qinghe Hall, 1st Floor, Building 1, Guangzhou Baiyun International Convention Center.
< img src = "/uploads/1786608748931-ck6r0v.jpg "alt =" Clean Shop Automation Line Interior "style =" max-width: 100%; height: auto; border-radius: 6px; box-shadow: 0 2px 12px rgba (0,0,0,0.08); "/>
< img src = "/uploads/1786608748316-j84grf.jpg" alt = "Invitation message: from manufacturing to intelligence" style = "max-width: 100%; height: auto; border-radius: 6px; box-shadow: 0 2px 12px rgba (0,0,0,0.08); "/>
Industry Outlook: Let the R&D strength of Chinese beauty win the respect of the world
At present, China's beauty industry is in a critical period of transition from scale expansion to quality improvement.Consumers are becoming more and more rational, regulation is becoming more and more standardized, and the underlying logic of market competition is shifting from "marketing-driven" to "product-driven".R&D strength, production standards, and supply chain resilience will become the core variables of brand competition in the next decade.
Micropeptide Group chose to build a smart factory in Zhaoqing, which is a strategic bet on this trend.As the invitation says: "Let the R&D strength of Chinese beauty win the attention and respect of the world."This is not only a vision for micropeptides, but also a direction for the entire industry to work together.
From 2012 to 2026, from one base to four bases, from cosmetics to cosmetics, each step of the micropeptide leap is inseparable from the trust and support of partners.On September 2, Micropeptide Group looks forward to meeting you in Zhaoqing and Guangzhou to share the moment of glory and start a new chapter of wisdom.
Guangdong Micropeptide Biotechnology Co., Ltd.
Customer Service Hotline: 020-31520790
24-hour consultation: 18126831382
Official website: weitaigd.com
Frequently Asked Questions (FAQs)
Q1: When does the Zhaoqing Smart Factory open?What's the address?
Opened on the morning of September 2, 2026, the factory address is located at A8, No. 2, Wende 5th Street, Zhaoqing High-tech Zone, Guangdong Province.Guests who are interested in attending can call the customer service hotline 020-31520790 to make an appointment in advance.
Q2: What are the production bases of Micropeptide Group?What is the total area?
Micropeptide Group currently has four major production bases in Guangzhou Baiyun, Foshan Nanhai, Hunan Changsha Ningxiang, and Zhaoqing High-tech Zone, with a total area of more than 300,000 square meters, including 3 cosmetic font size factories and 1 Class II medical device production factory.
Q3: What is "cosmetics union"?What are the advantages of micropeptides?
"Cosmetics" refers to having the production capacity and qualification of both cosmetics and second-class medical devices, and can provide the brand with a "cosmetics + equipment" combination product solution.Micropeptide's Class II medical device factories have passed ISO 13485 certification, and 3 cosmetic type factories have passed ISO 22716 and GMPC certification. The dual tracks empower each other in technology, quality control and management, so that the brand can complete multi-category layout at the same partner.
Q4: What will be the content of the Medical Research Co-Creation Summit on the afternoon of September 2?
The afternoon activities include a new product launch and a medical research co-creation theme summit.At the new product launch conference, the cutting-edge achievements of the industry will be released. The theme summit invited industry-university-research guests to share and exchange on the innovative path of efficacy skin care.The event location is Qinghe Hall, 1F, Building 1, Guangzhou Baiyun International Convention Center.Partners interested in attending can contact support to reserve a seat.
Q5: How do I work with the Micropeptide Group on OEM/ODM or medical devices?
The brand can call the customer service hotline 020-31520790 or the 24-hour hotline 18126831382 to explain the cooperation needs (cosmetics OEM/ODM, second-class medical devices, investment promotion, etc.). The customer service will arrange a dedicated business manager to connect and provide a customized cooperation plan. On the day of the event on September 2, you can also consult and communicate on-site.
